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To the Editor: Chikungunya virus (CHIKV) is a sin-
gle-stranded, positive-sense RNA virus of ≈11.8 kb mol-
ecules (1) belonging to the family Togaviridae and genus 
Alphavirus. Genotypes of CHIKV include Asian, East/
Central/South African (ECSA), and West African. CHIKV 
is endemic to Africa, southern Asia, and Southeast Asia and 
frequently causes debilitating but nonfatal illness.
CHIKV attracted global attention when a large epidem-
ic on Réunion Island in 2005–2006 spread rapidly to other 
parts of the world (1). The predominant strain during this ep-
idemic was the ECSA genotype with the A226V mutation of 
the E1 protein (2), the transmission of which is reported to be 
facilitated by Aedes albopictus mosquitoes (3). The ECSA 
genotype has been reported to circulate in Southeast Asia, 
including Malaysia, but not in Indonesia (4). Concern about 
circulating ESCA strains triggered alerts in 2009, when the 
Indonesian Ministry of Health reported an increasing num-
ber of chikungunya cases (3,529 cases in 2008, 83,756 in 
2009) (5). However, only Asian genotypes were detected (4). 
We investigated recent outbreaks of CHIKV in Indonesia 
and genotypes of associated CHIKV strains.
After chikungunya outbreaks were reported from 6 
districts in Indonesia (Tangerang, Karang Anyar, Ngawi, 
Jembrana, Mataram, and Kubu Raya), a team from the 
National Institute of Health and Research Development, 
Indonesian Ministry of Health, conducted field inves-
tigations from April through October 2011. This study 
received institutional review board approval (KE.01.06/
EC/373/2011).
Serum specimens from persons with fever >38°C who 
provided signed informed consent were tested at the Vi-
rology Laboratory, Center for Biomedical and Basic Tech-
nology of Health, National Institute of Health Research 
and Development, in Jakarta. Molecular examination by 
reverse transcription PCR (RT-PCR) of acute-phase serum 
specimens, selective for the E1 gene, was performed as pre-
viously described (6). Amplicons (330 bp) were sequenced 
for confirmation. The entire E1 gene of 2 identified ECSA 
genotypes was sequenced (7). A cladogram was created by 
using MEGA version.6.06 and the neighbor-joining meth-
od (8). The strength of the cladogram was estimated by 
bootstrap analyses that used 1,000 random samplings. To 
determine the circulating genotype of CHIKV in Indonesia, 
we compared these results with other reference sequences 
in GenBank. 
RT-PCR confirmed CHIKV in 28 (26%) of 109 sam-
ples from 5 districts: 12 (50%) in Mataram, 8 (47%) in Jem-
brana, 2 (40%) in Tangerang, 4 (21%) in Ngawi, and 2 (9%) 
in Kubu Raya. No samples from Karang Anyer were posi-
tive for CHIKV. Sequencing analysis revealed the A226V 
mutant (alanine to valine) ECSA genotype in 2 (7%) speci-
mens (GenBank accession nos. KJ729851, KH729852) and 
the Asian genotypes (KJ729829–50, KJ729853–56) in 26 
(93%) specimens. The Asian genotypes were closely re-
lated to those of CHIKV isolated from East Kalimantan, 
Bandung, Malaysia, and India (Figure).
The 2 cases associated with the A226V mutant ECSA 
genotype occurred in October 2011 in the Kubu Raya 
district, West Kalimantan, near the Malaysia border. Be-
cause both patients had no history of travel to Malaysia, 
where outbreaks involving the ECSA genotype had been 
reported, this finding demonstrates the emergence of the 
CHIKV A226V ECSA genotype in Indonesia. The 2008 
nationwide outbreak of chikungunya in Malaysia proved 
that A226V mutation enhances transmissibility of CHIKV 
by Ae. albopictus mosquitoes (9). Population movement 
from this region might contribute to the spread of this vi-
rus to Indonesia, which is a concern because of the high-
er transmissibility of the mutated ECSA strain through 
the Ae. albopictus mosquito vector, which is prevalent 
throughout Indonesia.
That ECSA genotypes were not found in other dis-
tricts during this investigation would suggest that this 
strain was not the source of the 2008–2009 outbreaks in 
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Indonesia, although this suggestion is by no means certain. 
The predominance of the Asian genotypes suggests ende-
micity of similar CHIKV strains.
A limitation of this study was the lack of serologic 
assays to confirm CHIKV infections, especially for those 
who sought care late after onset of illness. Because of 
the lack of reliable serologic assays with high sensitivity, 
some cases deemed by RT-PCR to be CHIKV negative 
might have been clinical cases of CHIKV infection (10). 
Thus, the A226V ECSA genotype of CHIKV was cir-
culating in Indonesia 5 years after the global pandemic 
and 2–3 years after the emergence of this strain from other 
Southeast Asian countries (4). Sensitive serology-based as-
says and rapid tests for different operational settings are 
needed, especially in those areas without molecular diag-
nostic capabilities. Also needed is surveillance of CHIKV 
throughout Indonesia so that health policy makers can 
have comprehensive data on the molecular epidemiology 
and prevalence of CHIKV infection. In addition, studies of 
CHIKV transmission by different vectors as well as virus 
and vector interactions are needed to provide an under-
standing of the emergence of the mutant strain across the 
region and to assist strategies for vector control and disease 
prevention and control.
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Figure. Cladogram of 
chikungunya virus, Asian 
and East/Central/South 
African genotypes, from 
chikungunya fever outbreaks 
in 6 districts in Indonesia, 
April–October 2011. Black 
dots indicate samples from 
patients. Scale bar indicates 
nucleotide substitutions per 
site. CHK, chikungunya; 
Chiks, chikungunya.
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To the Editor: Dengue is the most prevalent arthro-
pod-borne viral disease in tropical and subtropical coun-
tries. Every year, dengue virus (DENV) infections cause 
more than 50 million cases, 500,000 hospitalizations, and 
12,500 deaths worldwide (1). DENV belongs to the ge-
nus Flavivirus and is transmitted by Aedes spp. mosqui-
toes. There are 4 distinct serotypes (DENV-1 to DENV-4), 
and infection with 1 serotype does not provide long-term, 
cross-protective immunity against the other 3 serotypes.
In New Caledonia, DENV outbreaks have occurred 
since World War II and have been caused mainly by 1 se-
rotype/genotype introduced from a country to which den-
gue is hyperendemic. Since 2000, New Caledonia has had 
recurrent DENV-1 outbreaks (2). In 2014, circulation of 
DENV-1 and DENV-3 was still reported in this country (3).
Zika virus (ZIKV) is an emerging mosquito-borne vi-
rus that belongs to the genus Flavivirus and was first iso-
lated in Uganda (4). ZIKV is believed to be transmitted to 
humans by Aedes spp. mosquitoes. Before 2007, few hu-
man cases of infection had been reported. In 2007, the first 
Zika epidemic occurred in Yap, Federated States of Micro-
nesia (5). In October 2013, a ZIKV outbreak was reported 
in French Polynesia (6).
In New Caledonia, the first cases of ZIKV infection 
imported from French Polynesia were confirmed at the end 
of November 2013, and the first autochthonous cases were 
reported by mid-January 2014. Early in February 2014, 
the New Caledonia Health Authority declared an outbreak 
situation. Since February 2014, a total of 1,385 ZIKV lab-
oratory-confirmed cases have been detected, including 35 
imported cases (32 from French Polynesia, 2 from Vanuatu, 
and 1 from the Cook Islands). Concomitant with this ZIKV 
outbreak, circulation of DENV-1 and DENV-3 was report-
ed; >150 cases were biologically confirmed during Janu-
ary–September 2014 (3). Thus, New Caledonia currently 
has 3 arboviruses co-circulating.
In recent years, co-circulation of multiple DENV 
serotypes or DENV and chikungunya virus has been re-
ported. Although rare co-infections have been identified 
(7,8), given the similar clinical features and lack of con-
current testing, co-infections might not be identified. We 
report detection of ZIKV and DENV genomes in serum of 
a traveler (patient 1) who returned from French Polynesia 
where ZIKV and DENV were co-circulating (6,9) and in 
serum of a person (patient 2) in New Caledonia who had no 
travel history. The traveler was co-infected with ZIKV and 
DENV-3, and the local patient was co-infected with ZIKV 
and DENV-1.
Patient 1 was a 14-year-old boy who had fever 
(39.5°C), headache, arthralgia, asthenia, and myalgia. No 
hemorrhagic or neurologic findings were reported, and the 
patient recovered within 3 days. A complete blood count 
showed mild thrombocytopenia (platelet count 129 × 109 
platelets/L; reference range 150–400 × 109 platelets/L), 
leukopenia (leukocyte count 2.75 × 109 cells/L; reference 
range 4–10 × 109 cells/L) with associated stimulated lym-
phocytes, and discreet hepatic cytolysis (aspartate amino-
transferase 55 IU/L; reference value <34 UI/L, and alanine 
aminotransferase 51 IU/L; reference value <55 IU/L). Se-
rum was analyzed by using real-time reverse transcription 
PCR (RT-PCR) and was positive for ZIKV as recommend-
ed by Lanciotti et al. (5) and DENV-3.
Patient 2 was a 38-year-old woman who had fever 
(40°C), headache, arthralgia, asthenia, myalgia, retroor-
bital pain, conjunctivitis, diarrhea, nausea, and a diffuse 
pruritic maculopapular rash. No hemorrhagic or neurologic 
findings were reported, but signs of illness lasted ≈1 week. 
The patient had mild thrombocytopenia (platelet count 123 
× 109 platelets/L) and leukopenia (leukocyte count 2.65 × 
109 cells/L). Serum was analyzed by using RT-PCR (5) and 
was positive for ZIKV and DENV-1.
Co-infections were assessed by sequencing partial 
ZIKV membrane–envelope gene regions for isolates (Gen-
Bank accession nos. KM212963 and KM212967) from 
both patients, partial DENV-1 envelope gene for an isolate 
(KM212960) from patient 2, and partial DENV-3 nonstruc-
tural protein 5 gene for an isolate (KM212962) from patient 
1. Sequencing was conducted at La Plateforme du Vivant 
(Noumea, New Caledonia).
DENV-1 sequence obtained belonged to genotype 
I and clustered with DENV-1 sequences isolated in New 
Caledonia (2). DENV-3 sequence obtained  belonged to 
genotype III, similar to DENV-3 recently isolated in French 
Polynesia (9). ZIKV sequences obtained belonged to the 
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